55 Followers on Owler

Foghorn Therapeutics

is a Massachusetts-based clinical-stage biotechnology company that researches and develops gene therapies for the treatment of cancer and neurological disorders... Read more
OverviewCompetitorsFundingNews & Insights

Foghorn Therapeutics

is a Massachusetts-based clinical-stage biotechnology company that researches and develops gene therapies for the treatment of cancer and neurological disorders... Read more
Foghorn Therapeutics President & CEO: Adrian Gottschalk

President & CEO

Adrian Gottschalk

CEO Approval Rating

80/100

2016

PublicIndependent CompanyNASDAQFHTX

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
$22.6M
Employees
120
Funding
$306.6M

News

Conference Presentation
Feb 25, 2025
centralcharts
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Funding
May 23, 2024
MarketScreener
Foghorn Therapeutics received $110M in Post-IPO Equity Funding

Foghorn Therapeutics Competitors

1Arvinas
2Kymera
3Nurix
4C4T
5Vividion
6Cedilla
7IFM Therapeutics
8Axial Therapeutics
9Voyager
10Enlivex
Unlock 7 + competitors

Trending Companies